Infectious Agents and Cancer Epidemiology Research Webinar Series
- Upcoming Topics and Speakers
- Past Topics and Speakers
- EGRP Planning Committee
The Epidemiology and Genomics Research Program (EGRP) hosts a quarterly webinar series, "Infectious Agents and Cancer Epidemiology Research." The goals of this series are to:
- Highlight emerging and cutting-edge research related to infection-associated cancers that could be applied to cancer epidemiology;
- Share scientific knowledge about technologies and methods that may enhance and facilitate infection-associated cancer epidemiology research; and
- Foster cross-disciplinary discussions on infectious agents and cancer epidemiology.
Any interested individual is invited to participate. The webinars are free, but require pre-registration. Each presentation will be about 30 minutes in length and allow for 30 minutes of discussion moderated by EGRP staff. Instructions for connecting to the webinars will be sent via e-mail to individuals who register.
Infections are established etiologic factors in several cancers and contribute significantly to the global cancer burden. In 2008, it was estimated that 16.1% of newly diagnosed cancers were attributable to infections. The translational potential for this area of research is significant, as the identification of infections associated with cancers may lead to interventions such as treatment or vaccines to prevent associated cancers. As discussed in a blog post by NCI, DCCPS, EGRP, epidemiologic studies on the interplay of infectious agents and cancer induction could play important roles in answering both old and new questions, which could augment current knowledge and open new areas of research. Understanding the role of infectious agents in cancer may result in discoveries that could lead to better diagnosis, prevention, and treatment of cancers, particularly in resource-poor areas.
Upcoming Topics and Speakers
There are currently no upcoming webinars scheduled.
Note: Additional speakers and topics may be added in the future.
Past Topics and Speakers
December 11, 2017 2:00 p.m. to 3:00 p.m. EST
Shifting Trends in Cancer Risk and Burden Among People Living with HIV in the United States
Meredith Shiels, Ph.D., M.H.S.
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute
Dr. Shiels' research focuses on trends in cancer incidence and mortality, and the contribution of risk factors to these trends. She has a particular expertise in understanding cancer risk and burden among HIV-infected people, and is the co-Principal Investigator (PI) of the NCI’s HIV/AIDS Cancer Match Study. In this webinar, Dr. Shiels presented on the shifting trends in cancer risk and burden among people living with HIV in the United States.
September 21, 2017 1:00 p.m. to 2:00 p.m. EDT
HPV Natural History in HIV+ Women and Its Clinical Implications
Howard D. Strickler, M.D., M.P.H.
Head of the Division of Epidemiology and Harold & Muriel Block Chair in Epidemiology
Department of Epidemiology and Population Health, Albert Einstein College of Medicine
Dr. Howard Strickler presented on the HPV natural history in HIV+ women and relevant clinical complications. He is internationally recognized for his work on human papillomavirus (HPV) natural history in women who test positive for human immunodeficiency virus (HIV). His research has had a major impact on the current clinical guidelines for cervical cancer screening in women with HIV.
June 29, 2017 1:00 p.m. to 2:00 p.m. EDT
Epidemiology and Perinatal Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Sub-Saharan Africa
Charles Wood, Ph.D.
Nebraska Center for Virology, University of Nebraska-Lincoln, School of Biological Sciences
Dr. Wood's work focuses on HIV/AIDS and associated malignancies. He has served as the PI of several multi-center and multi-national collaborative projects, including serving as a Project Director for Biomedical Research Excellence award with 15-year funding from the NIH National Center for Research Resources (NCRR) to establish and sustain the Nebraska Center for Virology and serving as PI of a Fogarty International training grant on AIDS and associated malignancies. His largest ongoing collaborative research projects involve multiple U.S. research institutions, the University of Zambia School of Medicine and the University Teaching Hospital to study HIV/AIDS and Kaposi's sarcoma-associated herpesvirus (KSHV) transmission, disease pathogenesis, treatment and prevention. In this webinar Dr. Wood presented on the epidemiology and perinatal transmission of KSHV in Sub-Saharan Africa.
April 11, 2017 10:00 a.m. to 11:00 a.m. ET
The EMBLEM Study: A Resource for Molecular and Immunological Studies of Endemic Burkitt Lymphoma in East Africa
Sam Mbulaiteye, MBChB, M.Phil., M.Med.
Division of Cancer Epidemiology & Genetics (DCEG), National Cancer Institute
Dr. Mbulaiteye presented on the Epidemiology of Burkitt's Lymphoma in East-African Children and Minors (EMBLEM) Study, a multi-country and multi-year case-control study that is evaluating the role of repeated malarial infections, malaria genetic variants, and Epstein-Barr virus genetic variants in Burkitt's lymphoma.
December 1, 2016 2:00 p.m. to 3:00 p.m. EST
HPV Infection in Men, HPV Vaccine Trials, and the Role of HPV in Cancers
Anna R. Giuliano, Ph.D.
Founding Director, Center for Infection Research in Cancer (CIRC)
Moffitt Cancer Center
Dr. Anna Giuliano is the Founding Director of the Center for Infection Research in Cancer (CIRC) at the Moffitt Cancer Center. Her primary research focus is on the relationship between human papillomavirus (HPV) infections and cancer, including cervical, penile, anal, and oral cancers. Her work has contributed to the understanding of the rate at which HPV infections are acquired and cleared, the proportion that progress to disease, and HPV vaccine protection against multiple diseases in women and men. Dr. Giuliano presented on HPV infection in men, HPV vaccine trials, and the role of HPV in cancers.
September 20, 2016 11:30 a.m. to 12:30 p.m. EDT
Cutaneous Viral Infections as Potential Risk Factors for the Development of Non-Melanoma Skin Cancers
Dana E. Rollison, Ph.D.
Vice President, Chief Health Information Officer
Associate Member, Department of Cancer Epidemiology, Moffitt Cancer Center
Dr. Dana Rollison is currently the PI of the NCI-funded VIRUSCAN Study, a 5-year, prospective cohort study of cutaneous viral infections, UV exposure and risk of basal and squamous cell carcinomas being conducted among skin cancer screening patients attending the University of South Florida Dermatology Clinic. She is also collaborating with investigators in the Immunology Program to identify markers of immune function that may predispose to both cutaneous viral infections and NMSC. Her primary research focus is the molecular epidemiology of human polyomavirus and papillomavirus infections in relation to cancer. In this webinar, Dr. Rollison discussed cutaneous viral infections as potential risk factors for the development of non-melanoma skin cancers.
June 9, 2016 2:00 p.m. to 3:00 p.m. EDT
Annual Report to the Nation with a Focus on Liver Cancer: Risk Factors and Burden Are Unevenly Distributed in the Population
Sean Altekruse, D.V.M., M.P.H., Ph.D.
Epidemiologist, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute
Captain, Commissioned Corps of the U.S. Public Health Service
Dr. Sean Altekruse is an epidemiologist in the Surveillance Informatics Branch (SIB) of the Surveillance Research Program (SRP). His research interests include infection and cancer and prognostic tumor biomarkers. He is also the National Cancer Institute PI for the National Longitudinal Mortality Study. Dr. Altekruse presented on population-based liver cancer surveillance.
EGRP Planning Committee
- Hamdi Abdi, M.P.H., Cancer Research Training Award Fellow, Environmental Epidemiology Branch
- Katy Brignole, M.Sc., Cancer Research Training Award Fellow, Genomic Epidemiology Branch
- Danielle Carrick, Ph.D., M.H.S., Program Director, Genomic Epidemiology Branch
- Gary L. Ellison, Ph.D., M.P.H., Chief, Environmental Epidemiology Branch
- Gabriel Lai, Ph.D., Program Director, Environmental Epidemiology Branch
- Tram Kim Lam, Ph.D., M.P.H., Program Director, Environmental Epidemiology Branch
- Damali N. Martin, Ph.D., M.P.H., Program Director, Genomic Epidemiology Branch
- Vaurice L. Starks, B.S., Program Director, Methods and Technologies Branch
- Mukesh Verma, Ph.D., Chief, Methods and Technologies Branch
Questions about individual webinars or the series may be submitted via e-mail to the EGRP Planning Committee at IAandCancer@mail.nih.gov.